82
67
Growth Score 82 in past quarter
-6 pts
Heat Score 67 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1480990
Predemtec GmbH in Hennigsdorf develops a blood test for a reliable diagnosis of Alzheimer’s disease.
Annegret Feuerhelm-Heidl: Founder & CEOPast Role: Novartis, Team Member
About the Company
Predemtec focuses on the research, development, and manufacture of diagnostic tests to determine risk factors for dementia and other illnesses. Its DX test is a serum-based immunoassay used for early detection and risk diagnosis of senile dementia of the Alzheimer’s type.
Predemtec was founded in 2011 by Annegret Feuerhelm-Heidl.
